Feb 11 (Reuters) - BioRestorative Therapies Inc BRTX.O:
BIORESTORATIVE ANNOUNCES POSITIVE OUTCOME FROM TYPE B MEETING WITH FDA
BIORESTORATIVE THERAPIES INC: CURRENTLY ANTICIPATES THAT PHASE 3 TRIAL IND SUBMISSION WILL BE MADE IN SECOND HALF OF 2026
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.